Charles River Laboratories International Revenue and Competitors
Estimated Revenue & Valuation
- Charles River Laboratories International's estimated annual revenue is currently $3.4B per year.
- Charles River Laboratories International's estimated revenue per employee is $190,661
- Charles River Laboratories International's total funding is $1.5B.
- Charles River Laboratories International's current valuation is $17.9B. (January 2022)
Employee Data
- Charles River Laboratories International has 17990 Employees.
- Charles River Laboratories International grew their employee count by 2% last year.
Charles River Laboratories International's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder - Retrogenix | A Charles River Company | Reveal Email/Phone |
2 | Corporate VP, Global Discovery Business Development | Reveal Email/Phone |
3 | Corporate VP, Global GLP QA | Reveal Email/Phone |
4 | Corporate VP, Corporate Tax | Reveal Email/Phone |
5 | Corporate VP and General Manager, Microbial Solutions Division Charles River Labs | Reveal Email/Phone |
6 | Corporate VP, Finance, Corporate Controller | Reveal Email/Phone |
7 | Sr. VP Client Experience and Chief Marketing Officer | Reveal Email/Phone |
8 | Executive Director, North American RMS Sales & Marketing | Reveal Email/Phone |
9 | Executive Director, Global Sales Operations | Reveal Email/Phone |
10 | Corporate VP, Global Human Resources | Reveal Email/Phone |
Charles River Laboratories International Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $86.4M | 430 | 8% | N/A | N/A |
What Is Charles River Laboratories International?
From our headquarters near Boston, MA, Charles River Laboratories\' 8,000 employees serve clients in more than 50 countries. We are a global provider of solutions that advance the drug discovery and development process. Our leading-edge products and services are designed to enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, our products and services are organized into three categories spanning every step of the drug development pipeline: Research Models and Services, Preclinical Services, and Clinical Services.
keywords:N/A
$1.5B
Total Funding
17990
Number of Employees
$3.4B
Revenue (est)
2%
Employee Growth %
$17.9B
Valuation
N/A
Accelerator
Charles River Laboratories International News
That average rating earns Charles River Laboratories Intl. Inc an Analyst Ranking of 72, which means it ranks higher than 72 of stocks,...
Charles River Laboratories Intl. Inc also received an overall rating of 52, putting it above 52% of all stocks. Diagnostics & Research is ranked...
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading...
Following a summer filled with mergers and acquisitions, Charles River Laboratories has divested its research operations in Japan and a CDMO site in Sweden, engineering two separate deals expected to cut down $20 million in revenue. Tuesday, Charles River sold its ...
Commits to sourcing 100% renewable electricity and reducing 50% of greenhouse gas emissions from facilities by 2030 WILMINGTON, Mass.--(BUSINESS WIRE)--Jun. 7, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a long-term solar energy contract to address the enti ...
Other Companies in Wilmington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15380M | 26406 | 7% | N/A |
#2 | $5099.8M | 32902 | -4% | N/A |
#3 | $8620.9M | 42890 | N/A | N/A |